Carmine Stengone

Carmine Stengone

Director Ejecutivo en CONTINEUM THERAPEUTICS, INC. .

Fortuna: 282 742 $ al 31/08/2026

50 años
Health Technology
Consumer Services
Commercial Services

Perfil

Mr. Carmine N.
Stengone
is an Independent Director at Kiora Pharmaceuticals, Inc. and a President, Chief Executive Officer & Director at Contineum Therapeutics, Inc. He is on the Board of Directors at Kiora Pharmaceuticals, Inc. and Contineum Therapeutics, Inc. Mr. Stengone was previously employed as a Senior Vice President-Business Development by COI Pharmaceuticals, Inc., a President, Chief Executive Officer & Director by Avelas Biosciences, Inc., a President, Chief Executive Officer & Director by Afraxis, Inc., a Senior Director-Business Development by Phenomix Corp., a Senior Manager-Strategic Marketing by Anadys Pharmaceuticals, Inc., and a Principal by Johnson & Johnson Pharmaceutical Research & Development LLC.
He received his undergraduate degree from Wake Forest University, a graduate degree from Duke University and an MBA from Johnson Graduate School of Management.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
08/09/2026 17.217 ( 0,05 % ) 279 604 $ 31/08/2026
10/06/2026 1.250 ( 0,03 % ) 3 138 $ 31/08/2026

Cargos activos de Carmine Stengone

EmpresasCargoInicio
CONTINEUM THERAPEUTICS, INC. Director Ejecutivo 01/10/2018
KIORA PHARMACEUTICALS, INC. Director/Miembro de la Junta 01/08/2023

Antiguos cargos conocidos de Carmine Stengone.

EmpresasCargoFin
Director Ejecutivo 01/01/2018
Corporate Officer/Principal 01/10/2018
Corporate Officer/Principal 28/10/2010
Ventas & Marketing 01/01/2006
Corporate Officer/Principal 01/01/2004
Ver el detalle de la experiencia de Carmine Stengone.

Formación de Carmine Stengone.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

82

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas11

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Consumer Services

Health Services

Health Technology

Health Technology

  1. Bolsa de valores
  2. Insiders
  3. Carmine Stengone